Seeking Alpha

Steven Breazzano  

Steven currently focuses his analyses primarily on the valuation of smaller biotechs (100MM to 1 BB market cap) and utilizes all sources of information, including conversations with management, peer-reviewed publications, SEC filings, and all available primary and secondary research.

Steven is currently a consultant for a New York based life science focused consultancy, and brings a strong scientific and financial background to his current position.

Previously, Steven earned a Ph.D. from the Scripps Research Institute and an M.A. from Columbia University, with extensive work in the field of synthetic and medicinal chemistry, publishing several papers in prestigious peer-reviewed journals. He is also ...More
  • Description: Other. Trading frequency: Monthly
  • Interests: Options, Stocks - long, Stocks - short
Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no blog details. Click edit to add blog details.
Currently, you have no book details. Click edit to add book details.
Taro Pharmaceuticals: Last Week's Move Is Only The Beginning $TARO Jul 2, 2014